Cognitive disorders in patients with chronic kidney disease in pre-dialysis period

Автор: Anastasia A. Nikitina, Alexey E. Khrulev, Alexey N. Kuznetsov

Журнал: Saratov Medical Journal @sarmj

Статья в выпуске: 4 Vol.2, 2021 года.

Бесплатный доступ

Objective: to study the cognitive status of patients in the pre-dialysis period depending on the stage of chronic kidney disease (CKD) and the category of cardiovascular risk (CVR). Materials and Methods. We examined 98 patients with CKD in the pre-dialysis period (mean age 47.1±11.2 years). The patients were divided into three groups according to the criteria of CVR stratification. Group 1 consisted of 32 patients with a low or moderate CVR, and CKD stage C1 or C2; Group 2 included 34 patients with a high CVR and CKD stage C3a or C3b; Group 3 comprised 32 patients with a very high CVR and CKD stage C4. We used the SAGE test (Self-Administered Gerocognitive Examination) to evaluate cognitive functions. Results. Cognitive impairment (CI) was detected in 57% of the patients: 37.5% in Group 1, 44.1% in Group 2, and 90.5% in Group 3. Dementia was diagnosed in 19% of patients with CI. A correlation was found between the severity of CI, the degree of decrease in glomerular filtration rate, and the education level of CKD patients in the pre-dialysis period (p≤0.001). We established that the examined subjects with CKD were characterized by memory, constructive, spatial and logical thinking disorders. Conclusion. Chronic kidney disease is an independent risk factor for the development of CI. The latter progressed with both CKD stage and the patient’s CVR category, and was detected in 37.5% of patients with a low or moderate CVR, 44.1% of patients with a high CVR, and 90.5% of patients with a very high CVR.

Еще

Chronic kidney disease, cardiovascular risk, cognitive impairment, dementia, SAGE test

Короткий адрес: https://sciup.org/149139014

IDR: 149139014   |   DOI: 10.15275/sarmj.2021.0403

Список литературы Cognitive disorders in patients with chronic kidney disease in pre-dialysis period

  • Kam-Tao Li P, Garcia-Garcia G, Lui S-F, et al. Kidney health for everyone everywhere: From prevention to detection and equitable access to health care. Therapeutic Archive 2020; 92 (6): 4-14. [In Russ.]. https://doi.org/10.26442/00403660.2020.06.000545
  • Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease: A systematic review and meta-analysis. PLoS One 2016; 11 (7): e0158765. [In Russ.]. https://doi.org/10.1371/journal.pone.0158765
  • Chronic kidney disease: Clinical Guidelines. Association of Russian Nephrologists, 2019. [In Russ.].URL:http://nonr.ru/wpcontent/uploads/2020/01/Clin_guidlines_CKD_24.11_final-3-3.pdf (12 March 2020)).
  • Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. European Heart Journal 2020; 41 (1): 111-88. https://doi.org/10.1093/eurheartj/ehz455.
  • Nikitina AA, Khrulev AE. Cerebrovascular disorders in the pre-dialysis period of chronic kidney disease and the mechanisms of their development. Medical Almanac 2018; 56 (5): 28-32. [In Russ.].
  • Khrulev AE, Nikitina AA, Khruleva NS. Specific risk factors for cerebrovascular disorders in patients with chronic kidney disease in the pre-dialysis period. Cardiovascular Therapy and Prevention 2019; 18 (3): 88-93. [In Russ.]. https://doi.org/10.15829/1728-8800-2019-3-88-93
  • Polyakova IV, Borovkova NYu, Maslova TI, et al. On the vascular stiffness and cardiovascular risk in patients with chronic glomerulonephritis. Therapy 2019; 28 (2): 89-94. [In Russ.]. https://dx.doi.org/10.18565/therapy.2019.2.89-94
  • Rogova IV, Fomin VV, Damulin IV, et al. Vascular cognitive impairments in chronic kidney disease. Neurology, Neuropsychiatry, Psychosomatics 2015; 7 (1): 11-8. [In Russ.]..
  • Mark PB. Strategies to manage cardiovascular risk in chronic kidney disease. Nephrology Dialysis Transplantation 2017; 33 (1): 23-5. https://dx.doi.org/10.1093/ndt/gfx329
  • Khrulev AE, Studyanikova SF, Langraf SV, et al. Cognitive impairment in patients undergoing programmed hemodialysis. Neurology Bulletin 2019; 51 (2): 36-40. [In Russ.].
  • Khrulev AE, Tolbuzova DD, Plokhenko EA, et al. Cognitive status and risk factors for cognitive impairment in dialysis patients. General Intensive Care Medicine 2020; 16 (4): 21-31. [In Russ.]. https://doi.org/10.15360/1813-9779-2020-4-21-31
  • Etgen T, Chonchol M, Förstl H, Sander D. Chronic kidney disease and cognitive impairment: A systematic review and meta-analysis. Am J Nephrol 2012; 35 (5): 474-82. https://dx.doi.org/10.1159/000338135
  • Matsushita K, Mahmoodi BK, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012; 307 (18): 1941-51. https://dx.doi.org/10.1001/jama.2012.3954
  • Scharre DW, Chang S-I, Murden RA, et al. A brief cognitive assessment instrument for mild cognitive impairment (MCI) and early dementia. Alzheimer Dis Assoc Disord 2010; (24): 64-71. https://dx.doi.org/10.1097/WAD.0b013e3181b03277
  • Berger I, Wu S, Masson P, et al. Cognition in chronic kidney disease: A systematic review and meta-analysis. BMC Med 2016; 14 (206). https://doi.org/10.1186/s12916-016-0745-9
Еще
Статья научная